AMSTERDAM (AP) — AMSTERDAM (AP) — UniQure NV (QURE) on Tuesday reported a loss of $37.7 million in its second quarter.
On a per-share basis, the Amsterdam-based company said it had a loss of 69 cents.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 89 cents per share.
The human gene therapy company posted revenue of $5.3 million in the period, which did not meet Street forecasts. Three analysts surveyed by Zacks expected $7.1 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on QURE at https://www.zacks.com/ap/QURE
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
